Altre lingue Innoveren Scientific Inc.

Azioni

IVRN

US4041243076

Mercato chiuso - OTC Markets Altri mercati azionari 20:57:09 03/06/2024			Variaz. 5gg	Var. 1 gen.
0,0036 ^USD	-34,55%		-.--%	-96,90%

02/07	Innoveren Scientific Inc. annuncia le dimissioni di William Horne da membro del Consiglio di amministrazione	CI
06/03	Innoveren Scientific annuncia la presentazione 510(K) alla Food and Drug Administration federale degli Stati Uniti per Skindisc(Tm) Lite	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Innoveren Scientific Inc. Announces Resignation of William Horne as Member of the Board of Directors	02/07
Innoveren Scientific Inc. announced that it has received $0.25 million in funding	04/06
Innoveren Scientific : Announces Corporate Update - Form 8-K	22/05
Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	06/03
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/11
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc	10/07/23
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	10/07/23
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	22/05/23
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	10/05/23
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	10/05/23
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	18/04/23
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding	12/04/23
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/03/23
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding	24/02/23
H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC	29/12/22
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	29/12/22
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	28/12/22
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/11/22
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Innoveren Scientific Inc.

Azioni

IVRN

US4041243076

Altre lingue

Filtri